H2435 • 2025

An Act relative to APOL1 mediated kidney disease

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor: Gómez, Homar
Last action: 2026-03-16
Official status: Accompanied a study order, see H5234
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act relative to APOL1 mediated kidney disease

An Act relative to APOL1 mediated kidney disease By Representative Gómez of Easthampton and Senator Gomez, a joint petition (accompanied by bill, House, No.

What This Bill Does

An Act relative to APOL1 mediated kidney disease By Representative Gómez of Easthampton and Senator Gomez, a joint petition (accompanied by bill, House, No.
2435) of Homar Gómez, Adam Gomez and others relative to the gene associated with increased risk of end-stage renal disease.
Public Health.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2026-03-16 House
Accompanied a study order, see H5234
2025-09-11 House
Reporting date extended to Thursday, October 9, 2025
2025-06-06 Joint
Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
2025-02-27 House
Referred to the committee on Public Health
2025-02-27 Senate
Senate concurred

Official Summary Text

An Act relative to APOL1 mediated kidney disease
By Representative Gómez of Easthampton and Senator Gomez, a joint petition (accompanied by bill, House, No. 2435) of Homar Gómez, Adam Gomez and others relative to the gene associated with increased risk of end-stage renal disease. Public Health.

Current Bill Text

Read the full stored bill text

×

Bill H.2435

Chapter 111 of the General Laws is hereby amended by inserting after section 244, the following section:-

Section 245. The department of public health shall conduct a review and issue a report on variants of the apolipoprotein L 1 (APOL 1) gene associated with increased risk of end-stage renal disease. The report must include:

(1) Recommendations on how to increase awareness for APOL 1, including screening and genetic testing;

(2) An analysis of strategies and funding to increase screening and genetic testing for APOL 1 in the commonwealth; and

(3) Other relevant information or issues identified by the department.

The department of public health shall file the report with the clerks of the house of representatives and the senate and the joint committee on public health no later than December 31, 2026.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close